[1. KAPLAN ZS., JACKSON SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011; 2011:51-61.10.1182/asheducation-2011.1.51]Search in Google Scholar
[2. OMMEN SR., GİBBONS RJ., HODGE DO., THOMPSON SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997:79;812-4.10.1016/S0002-9149(96)00878-8]Search in Google Scholar
[3. PETERSEN AK., KRUMSİEK J., WÄGELE B., THEİS FJ., WİCHMANN HE., GİEGER C. On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics. 2012 Jun 6;13:120.10.1186/1471-2105-13-120353759222672667]Search in Google Scholar
[4. LEE YSG., BARADİ A., PEVERELLE M., SULTANİ R., ADAMS H, GARLİCK J., et al. Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography. Am J Cardiol. 2018 May 1;121(9):1021-1026.10.1016/j.amjcard.2018.01.01829606325]Search in Google Scholar
[5. YÜKSEL M., YILDIZ A., OYLUMLU M., AKYÜZ A., AYDIN M., KAYA H., et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015 Aug; 15(8):640-7.10.5152/akd.2014.5565533686525550173]Search in Google Scholar
[6. BHATTİ I., PEACOCK O., LLOYD G., LARVİN M., HALL RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197-203.10.1016/j.amjsurg.2009.08.04120122680]Search in Google Scholar
[7. GURSOY OM., KARAKOYUN S., KALCİK M., GOKDENİZ T., YESİN M., GUNDUZ S., et al. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol. 2014;113:860-864.10.1016/j.amjcard.2013.11.02924411287]Search in Google Scholar
[8. GARY T., PİCHLER M., BELAJ K., HAFNER F., GERGER A., FROEHLİCH H., et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8:e67688.10.1371/journal.pone.0067688369963423844064]Search in Google Scholar
[9. WİTKİEWİCZ W., KLİMECZEK P., IWANOWSKİ W., PASİCKA B., DOŁEGA-KOZİEROWSKİ B., DRELİCHOWSKİ S., et al. Dual source computed tomography in analysis of significance and morphology carotid plaques. Przegl Lek. 2013;70(3):118-122.]Search in Google Scholar
[10. LİAPİS CD., BELL PR., MİKHAİLİDİSM D., et al. ESVS guidelines. İnvasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009; 37:1-19.10.1016/j.ejvs.2008.11.00619286127]Search in Google Scholar
[11. SOYLU İA., CORTCU SA., UZUNKAYA F., ATALAY YO., BEKÇİ T., GÜNGÖR L., et al. The correlation of the platelet-to-lymphocyte ratio with the severity of stenosis and stroke in patients with carotid arterial disease. Vascular. 2017 Jun;25(3):299-306.10.1177/170853811667377027770030]Search in Google Scholar
[12. VARIM C., VARIM P., ACAR BA., VATAN MB., UYANIK MS., KAYA T., et al. Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. Kaohsiung Journal of Medical Sciences (2016) 32, 86-90.10.1016/j.kjms.2015.12.007]Search in Google Scholar
[13. MONETA GL, EDWARDS JM, TAYLOR LM JR, CHİTWOOD RW, LEE RW, CUMMİNGS CA et al. Correlation of North American Symtomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vase Surg. 1993;17(1):152-159.10.1016/0741-5214(93)90019-I]Search in Google Scholar
[14. BALTA S., OZTURK C. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680-1.10.3109/09537104.2014.97934025549287]Search in Google Scholar
[15. DURMUŞ E., KIVRAK T., GERİN F., SUNBUL M., SARİ I., ERDOGAN O. Neutrophil-to-lymphocyte ratio and and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Send to Arq Bras Cardiol. 2015 Dec;105(6):606-13.10.5935/abc.20150126469366526536980]Search in Google Scholar
[16. AKDAĞ S., AKYOL A., ASKER M., DUZ R., GUMRUKCUOGLU HA. Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis. Med Sci Monit. 2015 Nov 6;21:3395-400.10.12659/MSM.894774]Search in Google Scholar
[17. DERELİ S., BAYRAMOĞLU A., YONTAR OC. Usefulness of platelet to lymphocyte ratiofor predicting recurrence of atrial fibrillation after direct current cardioversion. Ann Noninvasive Electrocardiol. 2018 Nov 10:e12616.10.1111/anec.12616693175330414335]Search in Google Scholar
[18. YILDIZ A., YUKSEL M., OYLUMLU M., POLAT N., AKYUZ A., ACET H., et al. The utility of the platelet-lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial ınfarction. Clin Appl Thromb Hemost 2015 Apr;21(3):223-8.10.1177/107602961351985124431380]Search in Google Scholar
[19. YAYLA Ç., AKBOĞA MK., CANPOLAT U. Platelet to lymphocyte ratio can be a predictor of infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2015 Oct;66(9):831-6.10.1177/000331971557365825712290]Search in Google Scholar
[20. TEMİZ A., GAZİ E., GÜNGÖR Ö. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660-665.10.12659/MSM.890152399915924751474]Search in Google Scholar
[21. OZCAN CETİN EH., CETİN MS., ARAS D., TOPALOGLU S, TEMİZHAN A, KİSACİK HL., et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in-hospital and long-term major adverse cardiovascular events in ST segment elevation myocardial infarction. Angiology 2016;67:336-345.10.1177/000331971559175126101368]Search in Google Scholar
[22. AYÇA B., AKİN F., OKUYAN E. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets. 2015;26(8):816.10.3109/09537104.2015.101541025807323]Search in Google Scholar
[23. AZAB B., SHAH N., AKERMAN M., MCGİNN JT JR. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012 Oct;34(3):326-34.10.1007/s11239-012-0718-622466812]Search in Google Scholar
[24. OSADNİK T., WASİLEWSKİ J., LEKSTON A., STRZELCZYK J., KUREK A., GONERA M., et al. The platelet-tolymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. Saudi Heart Assoc. 2015 Jul;27(3):144-51.10.1016/j.jsha.2015.02.004448142026136628]Search in Google Scholar
[25. BOULOS NM., GARDİN JM., MALİK S., POSTLEY J., WONG ND. Carotid plaque characterization, stenosis, and ıntimamedia thickness according to age and gender in a large registry cohort. Am J Cardiol. 2016 Apr 1;117(7):1185-91.10.1016/j.amjcard.2015.12.062537135026869392]Search in Google Scholar
[26. HANSSON GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-95.10.1056/NEJMra04343015843671]Search in Google Scholar
[27. DOH JH., KOO BK., NAM CW., KİM JH., MİN JK., NAKAZATO R., et al. Diagnostic value of coronary CT angiography in comparison with invasive coronary angiography and intravascular ultrasound in patients with intermediate coronary artery stenosis: results from the prospective multicentre FIGURE-OUT (Functional Imaging criteria for GUiding REview of invasive coronary angiOgraphy, intravascular Ultrasound, and coronary computed Tomographic angiography) study. Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):870-7.10.1093/ehjci/jeu009411088524513881]Search in Google Scholar